Kelli Konst-Skwiot
Family Medicine · Glenwood Springs, CONPI 1982718441
Payments from drug & device makers
Across 263 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$615
- GSK$477
- Lilly USA, LLC$446
- Pfizer$179
- Biohaven Pharmaceuticals, Inc.$146
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,375100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 84 | $1,235 |
| AstraZeneca | 32 | $615 |
| GSK | 24 | $477 |
| Lilly USA, LLC | 39 | $446 |
| Pfizer | 11 | $179 |
| Biohaven Pharmaceuticals, Inc. | 7 | $146 |
| Astellas Pharma US Inc | 6 | $128 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $122 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $114 |
| Johnson & Johnson | 6 | $102 |
| E.r. Squibb & Sons, L.L.C. | 7 | $95 |
| Vanda Pharmaceuticals Inc. | 4 | $93 |
| Exact Sciences | 5 | $92 |
| Amgen | 5 | $84 |
| Eisai Inc. | 4 | $66 |
| Novo Nordisk | 3 | $48 |
| UCB, Inc. | 1 | $38 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| Organon | 2 | $30 |
| Merck | 2 | $27 |
| Novartis | 1 | $27 |
| Boston Scientific | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Harmony Biosciences LLC | 1 | $24 |
| Boehringer Ingelheim | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Sobi, Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$102
How this compares
$4,375 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 63 | $68,283 |
| OzempicSemaglutide | 49 | $47,516 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 58 | $45,188 |
| MounjaroTirzepatide | 16 | $17,054 |
| XareltoRivaroxaban | 15 | $16,621 |
| FarxigaDapagliflozin Propanediol | 15 | $14,633 |
| LinzessLinaclotide | 15 | $9,672 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $6,149 |
| Pregabalin | 97 | $5,920 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 119 | $5,090 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 76 | $3,900 |
| Gabapentin | 176 | $3,170 |
| Levothyroxine Sodium | 331 | $3,128 |
| Omeprazole | 130 | $2,842 |
| Pantoprazole Sodium | 149 | $2,795 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $179 | $68,28363 claims |
| Novo NordiskOzempic | $48 | $47,51649 claims |
| GSKTrelegy Ellipta | $477 | $45,18858 claims |
| AstraZenecaFarxiga, Symbicort | $615 | $17,40227 claims |
| Lilly USA, LLCMounjaro | $446 | $17,05416 claims |
| Johnson & JohnsonXarelto | $102 | $16,62115 claims |
| AbbVieLinzess | $1,235 | $9,67215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Glenwood Springs
- Clint FlanaganDacono$7.6M
- Larry OdekirkCastle Rock$6.3M
- Ripley HollisterColorado Springs$5.5M
- Timothy ColanderAurora$3.1M
- Mia ScottDenver$993K
- Matthew LewisAurora$960K
- Ethan LazarusDenver$688K
- Patrick BarryFraser$568K
- Astrid LampeyFraser$568K
- Kari UusinarkausWoodland Park$520K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.